Advertisements



Shire sells cancer drugs to Servier as Takeda circles

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceu.....»»

Category: videoSource: reutersApr 16th, 2018

Shire sells cancer drugs to Servier as Takeda circles

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceu.....»»

Category: videoSource: reutersApr 16th, 2018

Shire sells cancer drugs to Servier for $2.4B as Takeda circles

Shire said on Monday it would consider returning proceeds from the sale to shareholders through a buyback and that further selective disposals of non-strategic assets were possible......»»

Category: topSource: foxnewsApr 16th, 2018

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

LONDON (Reuters) - Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion......»»

Category: topSource: reutersApr 16th, 2018

Shire Sells Oncology Unit Ahead of Takeda"s Potential Offer

Shire (SHPG) sells its oncology segment to France-based Servier for $2.4 billion. T.....»»

Category: smallbizSource: nytApr 17th, 2018

Japan"s Takeda clinches $62 billion Shire deal as pharma M&A rolls on

LONDON/TOKYO (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry......»»

Category: topSource: reutersMay 8th, 2018

Japan"s Takeda sweetens $62 billion Shire offer

TOKYO/LONDON (Reuters) - Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals......»»

Category: topSource: reutersApr 20th, 2018

Shire to Sell Oncology Unit as Takeda Mulls Takeover

Shire has agreed to sell its oncology business to French drugmaker Servier for $2.4 billion, in a deal that could discourage Takeda from launching a takeover......»»

Category: smallbizSource: wsjApr 16th, 2018

Shire to Sell Oncology Unit for $2.4 Billion as Takeda Mulls Takeover

Shire has agreed to sell its oncology business to French drugmaker Servier for $2.4 billion, in a deal that could discourage Takeda from launching a takeover......»»

Category: smallbizSource: wsjApr 16th, 2018

Biotech developing cancer drugs kicks off $13M round with $5K pitch contest win

Rockville-based biotechnology company Remedy Plan Therapeutics took home $5,000 Thursday as the winner of the Maryland Tech Council's inaugural Bio+Tech18 pitch competition. That money will go toward a larger, $13 million round the company is looking .....»»

Category: topSource: bizjournalsSep 21st, 2018

Molecular Templates Surges 50%, Inks Cancer Deal With Takeda

Zacks.....»»

Category: topSource: redinewsSep 20th, 2018

Molecular Templates Surges 50%, Inks Cancer Deal With Takeda

Molecular Templates (MTEM) signs a collaborative.....»»

Category: dealsSource: nytSep 20th, 2018

Molecular Templates" stock soars after development deal with Takeda

Shares of Molecular Templates Inc. soared 44% in premarket trade Wednesday, after the developer of cancer treatments annou.....»»

Category: topSource: marketwatchSep 19th, 2018

AstraZeneca plots China robot offensive to counter price cuts

With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to become a broad healthcare provider in China......»»

Category: topSource: reutersSep 19th, 2018

OHSU"s resident iconoclast turns to podcasting to take on medicine"s hot topics

OHSU's Vinay Prasad, already know as a medical provocateur on Twitter, launches a new podcast to discuss everything from the hype around cancer drugs to Right-to-Try laws......»»

Category: topSource: bizjournalsSep 18th, 2018

Takeda reports clearance from SAMR of China for proposed acquisition of Shire

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 14th, 2018

Takeda gets China"s approval for $62 billion Shire purchase

Japan's Takeda Pharmaceutical Co Ltd said on Friday China's market regulator had approved its $62 billion acquisition of Shire Plc, bringing it closer to becoming a global top 10 drugmaker......»»

Category: topSource: reutersSep 14th, 2018

Roche steps up efficiency drive to take sting out of biosimilars

Roche , the world's biggest producer of cancer drugs, is stepping up cost cuts in an efficiency drive made unavoidable by competition from cut-price copies of three mega-brands from its famed U.S. Genentech biotech stable......»»

Category: topSource: reutersSep 13th, 2018

Takeda said to mull sale of Shire eye drug to cut debt, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Takeda weighs sale of Shire"s eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday......»»

Category: topSource: reutersSep 13th, 2018

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition......»»

Category: topSource: reutersSep 12th, 2018